$1.47
+8.1%HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
Warren Buffett's Owner Earnings DCF analysis for intrinsic value calculation
Base year metrics used for projections
Forecast period and terminal assumptions
Calculation flow from present value to intrinsic value per share
Operating Cash Flow - Maintenance CapEx = Owner Earnings
| Metric | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Year 6 | Year 7 | Year 8 | Year 9 | Year 10 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$14.1M | -$14.1M | -$14.2M | -$14.3M | -$14.4M | -$14.5M | -$14.6M | -$14.6M | -$14.7M | -$14.8M |
| Maintenance CapEx | -$120.7K | -$121.4K | -$122.1K | -$122.8K | -$123.5K | -$124.2K | -$124.9K | -$125.6K | -$126.3K | -$127.0K |
| Owner Earnings | -$14.2M | -$14.3M | -$14.4M | -$14.4M | -$14.5M | -$14.6M | -$14.7M | -$14.8M | -$14.9M | -$14.9M |
| Discount Factor | 0.926 | 0.857 | 0.794 | 0.735 | 0.681 | 0.630 | 0.583 | 0.540 | 0.500 | 0.463 |
| Present Value | -$13.1M | -$12.2M | -$11.4M | -$10.6M | -$9.9M | -$9.2M | -$8.6M | -$8.0M | -$7.4M | -$6.9M |
Continue your BEAT research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.